Clinical Trials in Multiple Cancer Indications
The Lumicell System has potential utility in multiple cancer indications, and is now being clinically evaluated in seven different cancer types in 18 medical centers across the United States.
For detailed information on Lumicell’s clinical trials, visit ClinicalTrials.Gov.
Completed Clinical Trials
Lumicell completed a Phase 1 safety study at Duke University Medical Center in breast cancer and sarcoma, a single-site Phase 2 feasibility study at Massachusetts General Hospital and a multi-center feasibility study in breast cancer. Results of the initial two studies are available in the following publications:
- Phase 1 results in Science Translational Medicine (January 2016)
- Single site Phase 2 (part A) results in Breast Cancer Research and Treatment (September 2018)
- Single site Phase 2 (part B) results in Annals of Surgical Oncology (January 2020)